8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2020 / Controlled feeding studies
Volunteers consumed either a 60% kcal fat meal (n=98) or a 36% kcal fat meal (n=62, placebo group). At least 87.5% of plasma LPS measurements in 32 tested participants were below the assay sensitivity (0.002 EU/mL). Although polymyxin B suppressed IL-1β (P = 0.035) and IL-6 (P = 0.0487) production in 3 h postprandial blood after 24 h incubation in the 60% fat study, the LPS present did not increase cytokine concentrations above fasting levels. In vitro lipoprotein lipase treatment significantly increased FFA and cytokine concentrations (P < 0.05) in both studies.
Mo Z, Huang S, Burnett DJ, et al. J Nutr, 2020. PMID 32040591
2020 / Randomized crossover trial
In a randomized crossover trial, 15 participants underwent 4 days of an alkalizing (BASE) or acidizing (ACID) diet under normoxic and normobaric hypoxic conditions. Anaerobic exercise performance was evaluated using the portable tethered sprint running (PTSR) test. Urinary pH, blood pH, blood bicarbonate concentration, and base excess were significantly higher following the BASE diet compared with the ACID diet (p < 0.001). However, there were no differences between BASE and ACID conditions for any of the PTSR-related parameters, indicating that diet-induced metabolic changes did not improve anaerobic performance.
Limmer M, Sonntag J, de Marées M, et al. Nutrients, 2020. PMID 32143278
2020 / Randomized controlled trial
Postmenopausal women aged 45-85 years (n = 129) were randomized to receive placebo or 75 mg trans-resveratrol twice daily for 12 months. Compared to placebo, resveratrol improved overall cognitive performance (P < 0.001) and attenuated the decline in cerebrovascular responsiveness (CVR) to cognitive stimuli (P = 0.038). The attenuation of CVR decline was associated with a reduction of fasting blood glucose (r = -0.339, P = 0.023).
Thaung Zaw JJ, Howe PRC, Wong RHX Nutrients, 2020. PMID 32244933
2020 / Randomized, double-blinded, placebo-controlled, crossover trial
In a randomized, double-blinded, placebo-controlled crossover study, 13 healthy overweight or obese adults received 1000 mg/d nicotinamide riboside (NR) and placebo for 6 weeks each. NR increased skeletal muscle markers of NAD+ synthesis, body fat-free mass (62.65% ± 2.49% vs 61.32% ± 2.58%; change: 1.34% ± 0.50%, P = 0.02), and sleeping metabolic rate. Skeletal muscle acetylcarnitine concentrations increased (4558 ± 749 vs 3025 ± 316 pmol/mg dry weight; change: 1533 ± 683, P = 0.04), along with exercise acetylcarnitine-forming capacity (P = 0.01). However, NR had no effects on insulin sensitivity, mitochondrial function, hepatic/intramyocellular lipid accumulation, cardiac energy status, cardiac ejection fraction, blood pressure, inflammation markers, or energy metabolism.
Remie CME, Roumans KHM, Moonen MPB, et al. Am J Clin Nutr, 2020. PMID 32320006
2020 / Randomized controlled intervention study
In Slovenia during winter, 105 healthy adults with suboptimal vitamin D status (25-OH-VitD 30-50 nmol/L) were randomized to three daily cholecalciferol formulations (1000 IU/25 µg as capsules, oil-based spray, or water-based spray) or a control group for two months. Supplementation significantly increased serum 25-OH-VitD levels compared to control (pooled Δc 32.8 nmol/L; 95% CI: 23.0, 42.5, p < 0.0001), with no significant differences between the formulations. Supplementation efficiency was associated with body mass index and baseline 25-OH-VitD, showing higher efficiency in participants with BMI < 25 and those with more pronounced insufficiency. The tested dosage was not sufficient to reach recommended levels in all subjects.
Žmitek K, Hribar M, Hristov H, et al. Nutrients, 2020. PMID 32365732
2020 / Intervention trial with matched controls
Adult-onset mitochondrial myopathy patients and matched controls received increasing doses of the vitamin B3 form niacin (up to 750-1,000 mg/day) for 10 or 4 months, respectively. Blood NAD+ increased in all subjects up to 8-fold, and muscle NAD+ in patients reached control levels. Muscle strength and mitochondrial biogenesis increased in all subjects, patients' muscle metabolomes shifted toward controls, and liver fat decreased by as much as 50%, though some patients showed an anemia tendency.
Pirinen E, Auranen M, Khan NA, et al. Cell Metab, 2020. PMID 32386566
2020 / Double-blind randomized crossover trial
A double-blind, randomized crossover trial in 51 women evaluated the cognitive effects of a high-saturated-fat meal compared to a high-oleic-sunflower-oil meal 5 hours postmeal, alongside baseline endotoxemia markers. Women had more difficulty distinguishing target stimuli from distractors after the high-saturated-fat meal than after the oleic-sunflower-oil meal (B = 4.44, SE = 1.88, P = 0.02). Higher baseline LBP and LBP:sCD14 were associated with less consistent, slower, and more erratic response times. Significant interactions showed that high baseline LBP and LBP:sCD14 erased between-meal differences, uniformly impairing attention.
Madison AA, Belury MA, Andridge R, et al. Am J Clin Nutr, 2020. PMID 32393980
2020 / Randomized controlled trial (secondary analysis)
In a secondary analysis of a factorial randomized trial involving 3,365 adults followed for 22.3 years, smoking was associated with increased risk of gastric cancer incidence (OR, 1.72; 95% CI, 1.003-2.93) and mortality (HR, 2.01; 95% CI, 1.01-3.98). Garlic supplementation was associated with reduced gastric cancer mortality exclusively among individuals who never drank alcohol (HR, 0.33; 95% CI, 0.15-0.75; interaction P = .03). No significant interactions occurred between vitamin supplementation and lifestyle behaviors.
Guo Y, Li ZX, Zhang JY, et al. JAMA Netw Open, 2020. PMID 32589229
2020 / Crossover, double-masked, randomized clinical trial
In a double-masked crossover trial, 57 glaucoma patients received oral placebo or nicotinamide (1.5 g/day for 6 weeks, then 3.0 g/day for 6 weeks) followed by crossover without washout. Saturated PhNR amplitude (Vmax) improved by 14.8% (95% CI: 2.8%, 26.9%; P = .02) on nicotinamide versus 5.2% (95% CI: -4.2%, 14.6%; P = .27) on placebo. The Vmax ratio improved by 12.6% (95% CI: 5.0%, 20.2%; P = .002) following nicotinamide compared to 3.6% (95% CI: -3.4%, 10.5%; P = .30) on placebo. Additionally, 27% of participants improved visual field mean deviation by ≥1 dB on nicotinamide with fewer deteriorating (4%) compared to placebo (P = .02).
Hui F, Tang J, Williams PA, et al. Clin Exp Ophthalmol, 2020. PMID 32721104
2020 / Randomized controlled trial (2 x 2 factorial)
In the VITAL-DEP randomized clinical trial, 18,353 participants aged 50 years or older were assigned to vitamin D3 (2000 IU/d) or placebo for a median duration of 5.3 years. Risk of depression or clinically relevant depressive symptoms did not significantly differ between the vitamin D3 group (12.9/1000 person-years) and placebo (13.3/1000 person-years; HR 0.97, 95% CI 0.87 to 1.09; P = .62). There were also no significant differences in depression incidence, recurrence, or change in PHQ-8 mood scores over time (mean difference 0.01 points, 95% CI -0.04 to 0.05 points).
Okereke OI, Reynolds CF, Mischoulon D, et al. JAMA, 2020. PMID 32749491
2020 / Consumer sensory evaluation study
Researchers evaluated whether using monosodium glutamate (MSG) to replace salt in four "better-for-you" dishes could match consumer acceptance while lowering sodium. A total of 163 consumers tasted standard-salt, reduced-salt, and reduced-salt plus MSG versions of roasted vegetables, a quinoa bowl, savory yogurt dip, and pork cauliflower fried rice. For all dishes, the MSG versions were liked the same as (or significantly more for the dip, P < 0.05) the standard recipe, and liked better than the reduced-salt recipe for the quinoa bowl and fried rice. MSG recipes of the quinoa bowl and dip were significantly preferred over standard recipes, leading authors to conclude MSG can mitigate sodium reduction without compromising acceptance.
Halim J, Bouzari A, Felder D, et al. J Food Sci, 2020. PMID 32776553
2020 / Randomized crossover trial
In the SWAP-MEAT crossover trial, 36 healthy adults consumed ≥2 servings/day of plant-based alternative meat versus animal meat for 8 weeks each with no washout period. Overall mean ± SEM TMAO concentrations were lower during the plant phase (2.7 ± 0.3 vs. 4.7 ± 0.9 µM, P = 0.012), though a significant order effect occurred; TMAO was significantly lower only in participants receiving plant meat second. LDL-cholesterol concentrations (109.9 ± 4.5 vs. 120.7 ± 4.5 mg/dL, P = 0.002) and body weight (78.7 ± 3.0 vs. 79.6 ± 3.0 kg, P < 0.001) were also significantly lower during the plant-based phase.
Crimarco A, Springfield S, Petlura C, et al. Am J Clin Nutr, 2020. PMID 32780794
2020 / Parallel-group, double-blind, randomized controlled trial
A parallel-group, double-blind trial randomized 159 patients with CKD stage 3b or 4 to receive 400 μg oral vitamin K2 (n=80) or matching placebo (n=79) once daily for 1 year. The study found no differences between groups in carotid-femoral pulse wave velocity at 12 months, augmentation index at 12 months, blood pressure, B-type natriuretic peptide, or physical function. Furthermore, an updated meta-analysis of trials conducted by the authors showed no effect of vitamin K supplementation on vascular stiffness or vascular calcification measures.
Witham MD, Lees JS, White M, et al. J Am Soc Nephrol, 2020. PMID 32817311
2020 / Randomized crossover trial
Twenty-two recreationally trained participants consumed vinegar (29 mL), sucrose (39 g), vinegar plus sucrose, or water alone in randomized order across four visits to evaluate effects on high-intensity cycling. Participants performed two cycle tests and a fatiguing test, ingested the supplement, rested for 90 minutes, and completed a third cycle test. There was no significant supplement by time interaction or main treatment effect (p > 0.05) on total time to exhaustion or heart rate.
Farney TM, Kowalsky RJ, Salazar DA, et al. Medicina (Kaunas), 2020. PMID 32867047
2020 / Randomized controlled trial (DIRECT-PLUS trial component) and lab assays
Researchers analyzed the vitamin B12 content of Wolffia globosa (Mankai) using lab assays and tested the effects of consuming 100 g/day of Mankai shake in an 18-month weight-loss trial (DIRECT-PLUS, n=294). Several bioactive cobalamin congeners were identified in Mankai extracts, with no pseudo B12 detected. Over 18 months, serum B12 levels increased by 5.2% in the control group, 9.9% in the Mediterranean diet group, and 15.4% in the green Mediterranean/low-meat diet group consuming Mankai (p = 0.025 between extreme groups).
Sela I, Yaskolka Meir A, Brandis A, et al. Nutrients, 2020. PMID 33049929
2020 / Double-blind, randomized, multicenter trial
A total of 13,078 statin-treated patients at high cardiovascular risk were randomized to receive 4 g/d of an omega-3 carboxylic acid formulation (EPA/DHA) or corn oil. The trial was prematurely halted for low probability of clinical benefit. The primary composite endpoint occurred in 12.0% of omega-3 CA patients versus 12.2% of corn oil patients (hazard ratio, 0.99 [95% CI, 0.90-1.09]; P = .84). A higher rate of gastrointestinal adverse events occurred in the omega-3 group (24.7%) compared to the corn oil group (14.7%).
Nicholls SJ, Lincoff AM, Garcia M, et al. JAMA, 2020. PMID 33190147
2020 / Randomized, double-blinded, placebo-controlled clinical trial
A 6-month trial examined the effects of vitamin D3, enhanced vitamin D2 in a mushroom matrix, standard mushroom, and placebo in 436 healthy adults aged ≥60 years. Total 25-OH-D and 25-OH-D3 levels were maintained in the vitamin D3 arm but decreased significantly (p < 0.05) in the other three arms. There were no significant effects of treatment on any measures of cognitive function or mood over 24 weeks.
Zajac IT, Barnes M, Cavuoto P, et al. Nutrients, 2020. PMID 33339304
2019 / Randomized controlled trial
Adults with self-reported depression were randomized to either a Mediterranean diet intervention (fortnightly food hampers, cooking workshops for 3 months, and fish oil for 6 months) or social groups fortnightly for 3 months. At 3 months, the MedDiet group showed a higher MedDiet score (t = 3.95, P < 0.01), greater reduction in depression (t = -2.24, P = 0.03), and improved mental health QoL (t = 2.10, P = 0.04), with benefits sustained at 6 months. Reduced depression correlated with higher MedDiet score (r = -0.298, P = 0.01), nuts (r = -0.264, P = 0.01), and vegetable diversity (r = -0.303, P = 0.01). Some correlations were also found between increased omega-3, decreased omega-6, and improved mental health.
Parletta N, Zarnowiecki D, Cho J, et al. Nutr Neurosci, 2019. PMID 29215971
2019 / Crossover trial
Researchers evaluated postprandial glucose and insulin responses to an oral glucose tolerance test (OGTT at 0800h vs 2000h, n=10) and a low GI meal consumed at 0800h, 2000h, and 0000h (n=9). In the OGTT, glucose iAUC was higher in the evening than morning (p=0.007). Following the low GI meal, glucose iAUC was higher at evening and midnight compared to morning (p=0.008, p=0.021), with no significant difference between evening and midnight (p=0.594). Insulin iAUC was also significantly higher at evening and midnight compared to morning (p=0.008 for both).
Leung GKW, Huggins CE, Bonham MP Clin Nutr, 2019. PMID 29248250
2019 / Randomized controlled trial
In 15 healthy women, brain responses to intragastric quinine-hydrochloride (10 µmol/kg) or placebo infusion were recorded using fMRI alongside appetite-related sensations, gastrointestinal hormones, and hedonic food intake. Quinine administration lowered octanoylated ghrelin (P<0.04), total ghrelin (P<0.01), and motilin (P<0.01) plasma levels, alongside lower prospective food consumption ratings (P<0.02) and hedonic food intake (P<0.05). Quinine also increased neural activity in the hypothalamus and hedonic brain regions but decreased activity in the homeostatic medulla (all pFWE-corrected<0.05).
Iven J, Biesiekierski JR, Zhao D, et al. Nutr Neurosci, 2019. PMID 29607741
2019 / Randomized, placebo-controlled trial (two-by-two factorial)
A randomized, placebo-controlled trial tested vitamin D3 (2000 IU/day) versus placebo for the prevention of cancer and cardiovascular disease over a median follow-up of 5.3 years in 25,871 participants. Vitamin D was not associated with a lower risk of invasive cancer (HR 0.96; 95% CI, 0.88 to 1.06; P=0.47) or major cardiovascular events (HR 0.97; 95% CI, 0.85 to 1.12; P=0.69). Secondary endpoints, including death from cancer (HR 0.83; 95% CI, 0.67 to 1.02) and death from cardiovascular causes (HR 1.11; 95% CI, 0.88 to 1.40), also showed no significant differences, and no excess risks of hypercalcemia or other adverse events were identified.
Manson JE, Cook NR, Lee IM, et al. N Engl J Med, 2019. PMID 30415629
2019 / Three experimental studies (laboratory and field)
Three studies examined the effect of a justification cue (license condition) versus no cue (control condition) on caloric consumption. In Studies 1 (N = 85) and 2 (N = 95), participants could eat freely from unhealthy snacks, while in Study 3 (N = 110), participants chose a snack at a take-out lunch place. Across all studies, caloric consumption was higher in the license condition compared to the control condition, with participants eating more unhealthy snacks in Studies 1 and 2 and choosing higher-calorie snacks in Study 3.
Prinsen S, Evers C, de Ridder DTD Psychol Health, 2019. PMID 30422003
2019 / Controlled trial
In a controlled trial, 49 strict vegan participants took oral creatine monohydrate (5 g daily, n = 31) or placebo (n = 18) for three weeks. Creatine intake normalized homocysteine levels in all participants and increased blood folic acid concentrations. Supplementation also increased baseline skin capillary density and endothelium-dependent capillary recruitment, while enhancing microvascular vasodilation specifically in participants with elevated baseline homocysteine.
Van Bavel D, de Moraes R, Tibirica E Fundam Clin Pharmacol, 2019. PMID 30506745
2019 / Clinical trial
Researchers evaluated isotope-labeled l-carnitine and gamma-butyrobetaine metabolism in 40 omnivores and 32 vegans or vegetarians. Following oral d3-l-carnitine, omnivores generated over 20-fold more d3-TMAO than vegans or vegetarians (P = 0.001), despite comparable fasting plasma carnitine levels. Gut bacteria transformed carnitine into gamma-butyrobetaine in both dietary groups, but conversion of gamma-butyrobetaine to TMA was induced by chronic carnitine intake and omnivorous habits.
Koeth RA, Lam-Galvez BR, Kirsop J, et al. J Clin Invest, 2019. PMID 30530985